Biotech

All Articles

Biogen, UCB file period 3 lupus gain after neglecting earlier trial

.Biogen and UCB's rely on developing in to stage 3 astride a failed research wants to have actually ...

Aptadir hopes new RNA preventions may turn around difficult cancers

.Italian biotech Aptadir Therapeutics has actually launched with the guarantee that its own pipeline...

Wave surfs DMD effectiveness to regulators' doors, delivering stockpile

.Surge Lifestyle Sciences has met its objective in a Duchenne muscular dystrophy (DMD) study, instal...

Sanofi plucks brand new CSO coming from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is going back to the pharma fold, occupyin...

Achilles drops cell treatment program, supports for layoffs after skipping 'business feasibility' objectives

.Achilles Therapeutics has actually destroyed its method. The English biotech is actually stopping w...

Aligos heralds period 2 MASH win, lowering liver body fat up to 46%

.Aligos Therapeutics is actually advertising a midstage succeed in metabolic-dysfunction associated ...

Basilea ratings $268M BARDA financing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work cultivating brand new antifungals has actually gotten a notable increa...

Capricor offers Europe liberties to late-stage DMD therapy for $35M

.Having presently scooped up the united state liberties to Capricor Therapeutics' late-stage Duchenn...

FDA fragments adcomm for Applied's unusual disease drug

.After pushing the selection meeting for Applied Therapeutics' metabolic disorder medication govores...

Novo inks $600M NanoVation deal to examine hereditary medications ex-liver

.Novo Nordisk is actually proceeding its press right into hereditary medications, agreeing to pay Na...